The board of directors of BeiGene, Ltd. announced that effective November 20, 2022, Dr. Alessandro Riva has been appointed as Co-Chair of the scientific advisory committee (the "Scientific Advisory Committee") of the Board. Dr. Corazon (Corsee) D. Sanders ceased to serve as Co-Chair of the Scientific Advisory Committee but remains a member of the Scientific Advisory Committee. The Scientific Advisory Committee consists of seven members, namely Dr. Margaret Han Dugan, Mr. Michael Goller, Mr. Thomas Malley, Dr. Alessandro Riva, Dr. Corazon (Corsee) D. Sanders, Dr. Xiaodong Wang and Mr. Qingqing Yi, with Dr. Xiaodong Wang and Dr. Alessandro Riva serving as Co-Chairs.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
162.2 USD | +0.15% | +5.65% | -10.04% |
05-02 | Amgen Posts Higher 1Q Revenue, Swings to Loss | DJ |
04-23 | Sector Update: Health Care Stocks Rise in Afternoon Trading | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.04% | 16.96B | |
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
+6.79% | 14.16B | |
+38.61% | 12.63B | |
+313.59% | 8.49B |
- Stock Market
- Equities
- BGNE Stock
- News BeiGene, Ltd.
- Beigene, Ltd. Announces Change of Co-Chair of Scientific Advisory Committee